Literature DB >> 20382501

Assessing the impact of incidental findings in a lung cancer screening study by using low-dose computed tomography.

Michael J Kucharczyk1, Ravi J Menezes, Alexander McGregor, Narinder S Paul, Heidi C Roberts.   

Abstract

PURPOSE: To assess the prevalence and nature of incidental findings (IF) seen in low-dose computed tomographies (LDCT) from a lung cancer screening study for at-risk individuals.
MATERIALS AND METHODS: Radiology reports from LDCTs of 4073 participants of a lung cancer screening study were retrospectively reviewed for findings other than lung nodules, that is, IFs, which were regarded as actionable. The frequency, nature, and expected cost of these IFs, and their anticipated follow-up were estimated.
RESULTS: There were 880 IFs described in 782 study participants (19%); the median age of the participants was 62 years (range, 46-80 years). More IFs were found in men (55%) than in women. The majority of these findings were noncardiovascular (76%), for which imaging was suggested for 74%. There were 7 severe IFs (0.8%) that merited immediate attention. Seven known cancers were diagnosed from follow-ups of the IFs. The majority of IFs (n = 486 [55%]) would require imaging follow-up if clinically indicated, with an estimated total a cost of CAN$45,500 to CAN$51,000 to provide initial diagnostic workup.
CONCLUSION: IFs on lung cancer screening studies are not uncommon and frequently require imaging or other follow-up for definitive diagnoses and to assess their clinical relevance. The implication of IFs has to be considered when determining a cost-effective and ethical protocol for the utilisation of LDCT in a high-risk population. 2011 Canadian Association of Radiologists. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20382501     DOI: 10.1016/j.carj.2010.02.008

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  28 in total

1.  Incidental findings in emergency imaging: frequency, recommendations, and compliance with consensus guidelines.

Authors:  Tarek N Hanna; Haris Shekhani; Matthew E Zygmont; James Matthew Kerchberger; Jamlik-Omari Johnson
Journal:  Emerg Radiol       Date:  2016-02-03

Review 2.  Screening for lung cancer with low-dose computed tomography: a review of current status.

Authors:  Henry M Marshall; Rayleen V Bowman; Ian A Yang; Kwun M Fong; Christine D Berg
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

Review 3.  Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.

Authors:  William C Black
Journal:  J Thorac Imaging       Date:  2015-03       Impact factor: 3.000

4.  A Randomized Study of Patient Risk Perception for Incidental Renal Findings on Diagnostic Imaging Tests.

Authors:  Stella K Kang; Laura D Scherer; Alec J Megibow; Leslie J Higuita; Nathanael Kim; R Scott Braithwaite; Angela Fagerlin
Journal:  AJR Am J Roentgenol       Date:  2017-11-15       Impact factor: 3.959

5.  Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods.

Authors:  Caroline Chiles; Fenghai Duan; Gregory W Gladish; James G Ravenel; Scott G Baginski; Bradley S Snyder; Sarah DeMello; Stephanie S Desjardins; Reginald F Munden
Journal:  Radiology       Date:  2015-03-09       Impact factor: 11.105

6.  Use of Imaging and Diagnostic Procedures After Low-Dose CT Screening for Lung Cancer.

Authors:  Shawn P E Nishi; Jie Zhou; Ikenna Okereke; Yong-Fang Kuo; James Goodwin
Journal:  Chest       Date:  2019-09-12       Impact factor: 9.410

7.  Comparing baseline symptom severity and demographics over two time periods in an outpatient palliative radiotherapy clinic.

Authors:  Luluel Khan; Justin Kwong; Janet Nguyen; Edward Chow; Liying Zhang; Shaelyn Culleton; Liang Zeng; Florencia Jon; May Tsao; Elizabeth Barnes; Cyril Danjoux; Arjun Sahgal; Lori Holden
Journal:  Support Care Cancer       Date:  2011-03-01       Impact factor: 3.603

Review 8.  Extrapulmonary neoplasms in lung cancer screening.

Authors:  Myrna C B Godoy; Charles S White; Jeremy J Erasmus; Carol C Wu; Mylene T Truong; Reginald F Munden; Caroline Chiles
Journal:  Transl Lung Cancer Res       Date:  2018-06

9.  Assessing the benefits and harms of low-dose computed tomography screening for lung cancer.

Authors:  Paul F Pinsky
Journal:  Lung Cancer Manag       Date:  2014

10.  High pitch third generation dual-source CT: Coronary and cardiac visualization on routine chest CT.

Authors:  Veit Sandfort; Mark A Ahlman; Elizabeth C Jones; Mariana Selwaness; Marcus Y Chen; Les R Folio; David A Bluemke
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.